The Company in a Nutshell
| Date Reviewed | 05/17/2026 |
| Company Name | International Flavors & Fragrances Inc |
| Symbol | IFF |
| Sector | Materials |
| Industry | Chemicals |
| Beta | 0.95 |
| PRO Rating | 2 |
| Dividend Safety | 1 |
Business Model
International Flavors & Fragrances Inc. is a creator and manufacturer of products for application in food, beverage, health and biosciences, scent and complementary adjacent products. Its segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.
| Current price | 79.21 |
| ROE | -2.60 % |
| ROIC | 0.00 % |
| Shareholder Yield | 0.25 % |
| 5-Yr Total Return | -40.65 % |
| 1-Yr Total Return | 3.05 % |
| Next Earnings Date | 08-04-26 |
Latest Quarter Information
What the CEO said:
Erik Fyrwald said, “IFF is off to a solid start in 2026,” highlighting “volume growth in all four segments, improved profitability, and … strong cash flow,” and added the company is “running a disciplined sale process for Food Ingredients to ensure we maximize value for shareholders.”
What we say:
2026-05-15, International Flavors & Fragrances Inc reported a mixed quarter performance on EPS and revenue with +116.6% and -3.6% respectively. Q1’26 revenue fell mainly from portfolio actions (divested/held-for-sale businesses) and FX, even though comparable currency-neutral sales grew 3% on higher volumes across all four segments. GAAP EPS improved because prior-year non-operational charges (incl. a Food Ingredients impairment) didn’t recur; adj EPS rose as volume/productivity lifted adj EBITDA to $568M and margin to 20.7%, partly offset by Scent input-cost pressure. Dividend $0.40 unchanged; FY26 guide reaffirmed.
Investment Thesis
Dividend Triangle
| 5-Yr Rev. Growth | 5.90 % |
| 5-Yr EPS Growth | 21.15 % |
| 5-Yr Div Growth | -12.30 % |
Potential Risks
| Debt/Equity | 0.45 |
| Financial Debt to EBITDA (TTM) | 2.80 |
| Current Ratio (Quarterly) | 1.40 |
| Credit Score | 51 |
Dividend Growth Perspective
| Dividend ($) | 1.6 |
| Dividend Yield Fwd | 2.00 % |
| Dividend Frequency | Quarterly |
| Average 5-Yr Yield | 2.85 % |
| Payout Ratio (%) | 0.00 |
| Cash Payout Ratio (%) | 102.75 |
| DGR 1-Yr (TTM) | 0.00 |
| DGR 3-Yr (TTM) | -20.95 |
| DGR 5-Yr (TTM) | -12.30 |
| DGR Streak | 21 |
| Chowder Score | -10.25 |
| Next DVD PMT | 07-10-26 |
Valuation
(Data for `ddm_growth_rate_years` field are missing to build DDM tables)
Video Tutorial: How to Read the Stock Cards DDM Valuation
| Market Cap | 19 B |
| PE Ratio | 22.65 |
| Fwd PE | 16.25 |
| Price to Book Ratio | 1.35 |
| DDM Valuation | 0 |
| Average 5-Yr PE | 250.47 |
| Value Score | 48 |